Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease

Douglas Adkins, Voravit Ratanatharathorn, Harry Yang, Barbara White

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease'. Together they form a unique fingerprint.

Medicine & Life Sciences